What is the specification of the tablets?

Each tablet contains 0.2g Fenbendazole and 10mg Ivermectin, with a total weight of 0.210g.

Where is the factory located?

Our factory is located at 9 Yugang Road, Zhengzhou Airport Economic Comprehensive Experimental Zone, Zhengzhou.

High Quality Veterinary Medicine GMP Factory Fenbendazole & Ivermectin Tablets

Name: High Quality Veterinary Medicine GMP Factory Fenbendazole & Ivermectin Tablets
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1943453412

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$0.99-1.99

1 bottle

Sample price:US$1.00/box.Request sample

Product profile

Customization

Available

Varieties

General Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Model NO.

TABLETS

Type

The First Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Prevent ThrowIing Expired Veterinary Drugs

Veterinary Reg. No.

160225858

Transport Package

Carton, Bucket

Specification

500 tablets/bottle

Trademark

MOOSUN

Origin

Zhengzhou, Henan Province

HS Code

3004909099

Production Capacity

50000 Bottles/Month

Key features

Dual-Action Formula: Combines Fenbendazole (0.2g) and Ivermectin (10mg) for effective anti-worm treatment.

Broad-Spectrum Efficacy: Treats nematode, tapeworm, and mite diseases in cattle, sheep, and swine.

OEM/ODM Support: Customized packaging and branding services available for global partners.

GMP Certified Factory: Manufactured in a GMP-certified facility with 20 R&D engineers and 360 staff.

Flexible Payment Terms: Accepts LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

Fast Lead Time: Consistent one-month lead time for both peak and off-season orders.

Global Export Experience: Exporting since 2016 to North America, Europe, Asia, and Africa.

Standard Packaging: 100 tablets per bottle, 80 bottles per box for convenient distribution.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤10.58h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.